Premium
Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL (A‐ROLL)
Author(s) -
Aydogan Fatİh,
Ozben Volkan,
Atasoy Denİz,
Yilmaz Mehmet Halİt,
Halaç Metİn,
Çelİk Varol
Publication year - 2010
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21450
Subject(s) - medicine , breast cancer , axillary lymph nodes , lymph node , lymph , occult , axillary lymph node dissection , axilla , radiology , surgery , metastasis , cancer , sentinel lymph node , pathology , alternative medicine
Background and Objectives Conventional surgical exploration to find clinically occult axillary lymph node recurrence of breast cancer can be challenging. The aim of this study was to determine the place of our alternative technique, axillary‐ROLL (A‐ROLL), in previously treated breast cancer patients with nonpalpable axillary lymph node recurrences. Methods Between March 2005 and May 2009, included in this retrospective study were four women (age, 42–51 years) without clinical evidence of distant metastasis who had treatment for breast cancer and were subsequently found to have suspicious axillary lymph node(s) detected by control ultrasonography (US) examination during follow‐up. A‐ROLL was utilized for the identification of lymph nodes. 0.5–1 mCi 99m Tc‐human serum albumin makroaggregate was injected under US guidance. A gamma probe was then used to guide the excision of the lymph nodes. Results The involved lymph nodes were successfully localized by A‐ROLL technique and removed surgically. Of all four patients, postoperative histopathologic examination revealed nodal cancer metastases in three patients (75%) and lymphoid hyperplasia in one patient. No complications occurred. Conclusions A‐ROLL technique has proved to be accurate and safe in the identification and excision of clinically occult axillary lymph node recurrence. J. Surg. Oncol. 2010;101:141–144. © 2009 Wiley‐Liss, Inc.